RxSight, Inc.RXSTNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +48.07% | +40.71% | +28.41% | -3.58% | -33.18% |
| Gross Profit Growth | +83.67% | +63.07% | +36.95% | +3.88% | -3.94% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +11.57% | +12.22% | +9.95% | +5.95% | +2.96% |
| Weighted Average Shares Diluted Growth | +11.57% | +12.22% | +9.95% | +5.95% | +2.96% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | -262.60% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +66.41% | +48.17% | +43.66% | +9.08% | -4.80% |
| Inventory Growth | +14.53% | +26.34% | +26.06% | +28.89% | +33.58% |
| Asset Growth | +70.73% | +74.51% | +70.91% | +1.15% | -0.62% |
| Book Value per Share Growth | +53.89% | +56.28% | +54.97% | -4.65% | -3.32% |
| Debt Growth | +239.46% | +308.23% | +377.48% | +2.67% | +2.31% |
| R&D Expense Growth | +24.46% | +25.42% | +29.09% | +23.23% | +2.51% |
| SG&A Expenses Growth | +33.78% | +33.28% | +22.77% | +19.28% | +6.78% |